SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 162 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $7,270,000 | +2275.8% | 55,000 | +431.4% | 0.46% | +2455.6% |
Q1 2017 | $306,000 | +7.7% | 10,350 | 0.0% | 0.02% | -47.1% |
Q4 2016 | $284,000 | -92.0% | 10,350 | -82.1% | 0.03% | -86.5% |
Q3 2016 | $3,556,000 | +1170.0% | 57,900 | +293.9% | 0.25% | +769.0% |
Q2 2016 | $280,000 | -70.7% | 14,700 | -70.0% | 0.03% | -60.8% |
Q1 2016 | $956,000 | -36.5% | 48,971 | +25.6% | 0.07% | -69.9% |
Q4 2015 | $1,505,000 | – | 39,000 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |